Cargando…
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report
Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly progressive tumor with a poor prognosis. Although immune checkpoint inhibitors have been approved for treatment of both small cell and non–small cell lung cancers, their role in the treatment of LCNEC is unclear. We describ...
Autores principales: | Watanabe, Masayuki, Matsumura, Yuki, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527153/ https://www.ncbi.nlm.nih.gov/pubmed/36064196 http://dx.doi.org/10.1111/1759-7714.14615 |
Ejemplares similares
-
Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips
por: Matsumura, Yuki, et al.
Publicado: (2022) -
Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report
por: Okabe, Naoyuki, et al.
Publicado: (2021) -
A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib
por: Matsumura, Yuki, et al.
Publicado: (2021) -
Our experience of lung resection in patients who decline blood transfusion for religious reasons
por: Takagi, Hironori, et al.
Publicado: (2021) -
Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs
por: Takagi, Hironori, et al.
Publicado: (2022)